Skip to content
10-Q

Quarterly Report

BIOSCIENCE HEALTH INNOVATIONS INC. BHIC

0001185185-24-000542

← back to feed
Filed
May 17, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · May 13, 2024 5.46M sh
Operating Cash Flow Q2 2023 · Feb 28, 2023 −$47.46K
Operating Cash Flow Q2 2023 · Feb 28, 2022 −$30.93K
Stockholders Equity Q2 2023 · Feb 28, 2023 $5.49K
Stockholders Equity Q2 2023 · Aug 31, 2022 $14.39K
Stockholders Equity Q2 2023 · Feb 28, 2022 $55.59K
Stockholders Equity Q2 2023 · Aug 31, 2021 −$12.79K
Total Liabilities Q2 2023 · Feb 28, 2023 $3.3K
Total Liabilities Q2 2023 · Aug 31, 2022 $1.86K
Current Assets Q2 2023 · Feb 28, 2023 $8.79K
Current Assets Q2 2023 · Aug 31, 2022 $16.25K
Total Assets Q2 2023 · Feb 28, 2023 $8.79K
Total Assets Q2 2023 · Aug 31, 2022 $16.25K
Eps Basic Q2 2023 · Feb 28, 2023 $0.00
Eps Basic Q2 2023 · Feb 28, 2023 $0.00
Eps Basic Q2 2023 · Feb 28, 2022 $0.00
Eps Basic Q2 2023 · Feb 28, 2022 $0.00
Sga Expense Q2 2023 · Feb 28, 2023 $20.01K
Sga Expense Q2 2023 · Feb 28, 2023 $48.93K
Sga Expense Q2 2023 · Feb 28, 2022 $26.24K
Sga Expense Q2 2023 · Feb 28, 2022 $40.33K
Net Income Q2 2023 · Feb 28, 2023 −$19.99K
Net Income Q2 2023 · Feb 28, 2023 −$48.9K
Net Income Q2 2023 · Feb 28, 2022 −$17.53K
Net Income Q2 2023 · Feb 28, 2022 −$31.62K
Operating Income Q2 2023 · Feb 28, 2023 −$20.01K
Operating Income Q2 2023 · Feb 28, 2023 −$48.93K
Operating Income Q2 2023 · Feb 28, 2022 −$26.24K
Operating Income Q2 2023 · Feb 28, 2022 −$40.33K
Revenue Q2 2023 · Feb 28, 2023 $0
Revenue Q2 2023 · Feb 28, 2023 $0
Revenue Q2 2023 · Feb 28, 2022 $0
Revenue Q2 2023 · Feb 28, 2022 $0